We believed that the nasal strips had died in the 90. It turns out that they were just waiting for Instagram to get them fashionable

The small adhesive bands that stick in the nose are again very common on slopes, gyms and popular races after decades of oblivion. Why is it important. From Carlos Alcaraz Even weekend runners, the phenomenon of nostrils has exploded in the last year. It is no accident: It reflects both the obsessive search for marginal advantages in sport … … as our complex relationship with Gadgets –electronic or not– that promise instant improvements. The context. The nasal strips were born in the 80s as an antironquid remedy. They jumped to sport in the mid -90s when Jerry Rice wore them in the Super Bowl (today keep entering money by promoting them) and Ronaldo popularized them in football. They promised to “increase the nasal air flow by 31%” and became the sports avant -garde symbol of the time. And they went down in cascade, reaching the semi -professional and also to the amateur who simply wanted to leverage them to increase their performance. The fall. By 2000, science began to disassemble them. A study by the University of Buffalo with 13 athletes He concluded that they did not improve performance in intense exercises. The reason is simple: when the effort goes up, we breathe through the mouth, not by the nose. The strips became irrelevant. The return. Carlos Alcaraz took them A month ago in the Masters of Romeand in addition to black color: even more evident than the classic shiver. Several Barça players uploaded a photo on a planeall with the strips set, to “improve rest.” And new companies such as Gudslip or histrips have “reversed” them with somewhat more comfortable designs and marketing aimed at athletes of all levels. Also with Machacona advertising on Instagram. Yes, but. A 2021 review which analyzed 19 studies did not find significant differences in Vo2max –A key metric–, heart rate or performance. The strips reduce nasal resistance, but only help in light efforts or when there is congestion. In intense exercise, they are useless. For elite athletes, any 1% improvement can be decisive. Alcaraz uses them strategically when it is congested. Amateurs, less accustomed to extreme suffering, can perceive greater subjective benefit in respiratory comfort. In fact, who writes these lines tested them and the highest air entry is noticed. But not the remarkable improvement in performance. And we must not lose sight of the mental factor: in sport, there is very often a psychological component in certain practices. The use of strips can give mental confidence, reduce pre-compensation stress and be part of the ritual that reassures the athlete, which makes him feel control. What is happening. There are five great forces promoting this boom: Greater conscience that once on nasal breathing in sport. Products that have improved: grip, comfort and even appearance. Virality in social networks. Examples in elite sport. And low risk profile. On the latter: the strips of certain brands usually cost between and one euro the unit. They are a performance experiment that comes out cheap. Deepen. The strips do work during sleep. They reduce snoring and improve rest. For athletes with rhinitis or exercise induced asthma, they can be useful. In healthy people doing intense sports, its effect is mainly placebo. Abel Antón, who won World Cups with and without them, summarizes it in a phrase pronounced a Relief Two years ago: “Believing that something is doing well makes us work much better.” Outstanding image | Pneuma Nasal Tape In Xataka | I have run, swim and worked with the Aqua Suunto. Under water I understood what these bone driving headphones propose

FDA approves Johnson & Johnson nasal spray for depression

The Food and Drug Administration (FDA) has approved a new form of treatment for treatment-resistant depressionwhich could represent a key alternative for many patients who do not respond to conventional treatments. This is Spravato, a nasal spray developed by Johnson & Johnson, which can be used independently, without the need to be accompanied by an oral antidepressant. This advance promises to transform the lives of the millions of people who suffer from major depressive disorders and who cannot improve with standard treatments. Spravato was initially approved in 2019 as an adjunct to oral antidepressants, but with this new approval, it can now be used as a single therapy for those patients with treatment-resistant depression. This condition affects one-third of the approximately 21 million adults in the United States who suffer from major depression, who show no improvement despite trying at least two different antidepressant treatments. Bill Martin, head of global neuroscience at Johnson & Johnson, highlighted the importance of this medication, highlighting that untreated depression can be fatal, especially when patients experience suicidal thoughts. According to estimates, Major depression can include symptoms such as persistent sadness, fatigue, sleep disorders, and self-destructive thoughts. which puts patients at high risk of harm or death if not treated appropriately. Spravato, whose active ingredient is ketamine, has been shown to be effective in inducing relief from depressive symptoms in the short term. In clinical studies, patients began to experience improvements in their emotional state just 24 hours after treatment, and the beneficial effects continued for at least a month. This speed is a fundamental difference compared to traditional antidepressants, which can take weeks or even months to take effect. The spray should be administered under medical supervision The nasal spray is administered in a clinical setting under close medical supervision due to the risks of serious side effects such as sedation, dissociation, respiratory depression, and suicidal thoughts. Therefore, patients should remain under observation for at least two hours after administration.. This restrictive and supervised approach is essential to ensure patient safety while reaping the benefits of the medication. Although the rollout of Spravato was slow, especially due to complications from the pandemic, doctors and mental health facilities have begun to embrace the use of the medication more frequently. FDA approval as a stand-alone therapeutic option reinforces confidence in its effectiveness and safety. Results from a phase four trial confirmed that the drug has a safety profile consistent with previous data and provides both rapid and long-lasting relief. Dr. Gregory Mattingly, president of the Midwest Research Group, who participated in the clinical trials, noted that patients now have the option of choosing whether to take Spravato along with an oral antidepressant or on its own. allowing them to avoid the undesirable side effects of oral medications, such as weight gain or sexual problems. The ability to personalize treatment is one of the great advantages of this approach. In terms of economic impact, Spravato has been a success for Johnson & Johnson. During the first nine months of 2024, the drug generated sales of $780 million, and the company expects revenue to increase even further in the future, reaching between $1 billion and $5 billion annually. Keep reading:

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.